• Emmessar Biotech board meeting on May 12, 2026 to approve audited FY26 financial results.
• Trading window closure for equity shares extended until May 14, 2026 per SEBI insider trading regulations.
• Disclosure made pursuant to SEBI LODR Regulation 29(1)(a) requirements for listed companies.